Pre-market Hot Trades in US Stocks

eLong Power is down 8.68% in pre-market trading. Based on recent news,

1. On July 31, concerns about the company's integration obstacles weighed on its stock price. eLong Power Holding Limited completed public offerings of $6 million and $6.6 million in May and July, respectively, but its stock price has remained sluggish throughout the year.

2. On August 1, market skepticism regarding the company's business transparency heightened investor unease, leading to further declines in stock price.

3. On August 2, despite other companies like NVE Corp reporting strong quarterly performance, eLong Power failed to provide significant operational updates, further undermining market confidence. The market remains highly sensitive to the capital-raising environment for small-cap stocks.

Credo Tech is down 3.37% in pre-market trading. Based on recent key news:

1. On August 2, analyst Murphy reiterated expectations for accelerated bookings, anticipating that AI network groups will move together. Credo, as a high-beta stock in the connectivity layer, has a beta value close to 3.2, and the market's willingness to pay for it will be revealed in August. This has led to stock price volatility.

2. On August 1, analysts are focused on whether Credo's Q1 FY27 performance can justify the reset. If conditions are met, its leadership in AI infrastructure will continue this fall. This has impacted the stock price. Increased demand for AI infrastructure has garnered high market attention.

Top Gainers in Pre-market US Stocks

Hydrofarm is up 559.26% in pre-market trading. Based on recent key news:

1. On August 3, Hydrofarm successfully completed the sale of Aurora Peat Products, marking an important milestone for the company. This sale brought substantial revenue to the company, driving a significant increase in stock price.

2. On August 3, Hydrofarm launched Project Agility, aimed at enhancing and expanding its logistics service platform. This move will optimize operations, improve efficiency, and further drive the company's stock price upward.

3. On August 3, the company's management released a statement emphasizing the risks and uncertainties facing future development but remained optimistic about the company's growth. Despite the risks, market confidence in the company's future has strengthened, resulting in a rise in stock price. The demand for logistics services is strong, and the industry outlook is optimistic.

AiRWA is up 195.17% in pre-market trading. Based on recent key news:

1. On July 31, AiRWA announced its plan to launch the AiRWA exchange focused on the tokenization of US stocks. The company combines AI-driven enterprise services with intellectual property licensing and expands its business in the global digital asset market. This diversified technological and financial strategy supports its current expansion and acquisition activities, driving a significant increase in stock price

2. On July 30, documents released by the U.S. Securities and Exchange Commission showed that AiRWA is actively seeking innovation, particularly in the field of digital finance, which further enhances market confidence in its future growth.

3. Recent technical indicators have shown strong sell signals; nevertheless, the market remains optimistic about its future strategic layout, leading to significant fluctuations in stock prices in the short term. Digital financial innovation is driving increased market confidence.

Nature's Way Pharmaceuticals rose 110.44% in pre-market trading. Based on recent key news:

1. On August 1, Nature's Way Pharmaceuticals released important information through the EDGAR system, which may be related to its significant stock price increase. This information was published by the electronic data gathering, analysis, and retrieval system operated by the U.S. Securities and Exchange Commission, indicating that the company released original content on July 31.

2. On August 3, Addentax Group Corp's stock price fell 17.5% in pre-market trading, while Apnimed Inc and Alvotech SA also dropped 9.4% and 7.3%, respectively. The stock price fluctuations of these companies may impact market sentiment.

3. On August 3, Alvotech SA announced that the FDA had closed its inspection of the Reykjavik production facility and classified the site as a voluntary action indicated, which may affect its stock price. Recent fluctuations in the pharmaceutical industry are significant and warrant attention